Edible solid foams as porous substrates for inkjet-printable pharmaceuticals

FDA, Paving the way for personalized medicine, 2013. E. Cone, A. Gregory, Healthcare Gets Personal, Oxford, 2016. http://www.oxfordeconomics.com/my-oxford/projects/330885 (accessed 08.08.17). Pritchard, 2017, Strategies for integrating personalized medicine into healthcare practice, Per. Med., 14, 141, 10.2217/pme-2016-0064 Schork, 2015, Personalized medicine: time for one-person trials, Nature, 520, 609, 10.1038/520609a Lind, 2017, Social aspects in additive manufacturing of pharmaceutical products, Expert Opin, Drug Deliv. 14 Alomari, 2015, Personalised dosing: Printing a dose of one’s own medicine, Int. J. Pharm., 494, 568, 10.1016/j.ijpharm.2014.12.006 Kolakovic, 2013, Printing technologies in fabrication of drug delivery systems, Expert Opin. Drug Deliv., 10, 1711, 10.1517/17425247.2013.859134 Cheow, 2015, Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs, Eur. J. Pharm. Biopharm., 96, 314, 10.1016/j.ejpb.2015.08.012 Montenegro-Nicolini, 2017, Inkjet printing of proteins: an experimental approach, AAPS J., 19, 234, 10.1208/s12248-016-9997-8 GlaxoSmithKline plc, Liquid dispensing technology (LDT), 2015. http://www.gsk.com/media/279688/liquid-dispensing-technology-leaflet.pdf (accessed 26.09.16). Edinger, 2017, Visualization and non-destructive quantification of inkjet-printed pharmaceuticals on different substrates using Raman spectroscopy and Raman chemical imaging, Pharm. Res., 34, 1023, 10.1007/s11095-017-2126-2 Genina, 2013, Evaluation of different substrates for inkjet printing of rasagiline mesylate, Eur. J. Pharm. Biopharm., 85, 1075, 10.1016/j.ejpb.2013.03.017 Buanz, 2011, Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing, Pharm. Res., 28, 2386, 10.1007/s11095-011-0450-5 D. Raijada, N. Genina, D. Fors, E. Wisaeus, J. Peltonen, J. Rantanen, N. Sandler, A step towards development of printable dosage forms for poorly soluble drugs, 102 (2013) 3694–3704. doi: 10.1002/jps.23678. Hirshfield, 2014, Dropwise additive manufacturing of pharmaceutical products for solvent-based dosage forms, J. Pharm. Sci., 103, 496, 10.1002/jps.23803 Genina, 2013, Behavior of printable formulations of loperamide and caffeine on different substrates - effect of print density in inkjet printing, Int. J. Pharm., 453, 488, 10.1016/j.ijpharm.2013.06.003 Dixit, 2009, Oral strip technology: overview and future potential, J. Control. Release, 139, 94, 10.1016/j.jconrel.2009.06.014 Pardeike, 2011, Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines, Int. J. Pharm., 420, 93, 10.1016/j.ijpharm.2011.08.033 Elele, 2010, Electrodeless electrohydrodynamic printing of personalized medicines, Appl. Phys. Lett., 97, 10.1063/1.3524512 Palo, 2017, Development of oromucosal dosage forms by combining electrospinning and inkjet printing, Mol. Pharm., 14, 808, 10.1021/acs.molpharmaceut.6b01054 Elele, 2012, Electrodeless elctrohydrodynamic drop-on-demand encapsulation of drugs into porous polymer films for fabrication of personalized dosage units, J. Pharm. Sci., 101, 2523, 10.1002/jps.23165 Siimon, 2015, Mechanical characterization of electrospun gelatin scaffolds cross-linked by glucose, J. Mater. Sci. - Mater. Med., 26, 37, 10.1007/s10856-014-5375-1 Zhang, 2017, Electrospinning design of functional nanostructures for biosensor applications, J. Mater. Chem. B, 5, 1699, 10.1039/C6TB03121H Liu, 2017, Electrospinnability of Poly Lactic-co-glycolic Acid (PLGA): the role of solvent type and solvent composition, Pharm. Res., 34, 738, 10.1007/s11095-017-2100-z L. Rey, J.C. May, D.Q. Wang, Freeze-drying/lyophilization of pharmaceutical and biological products, in: L. Rey, J.C. May (Eds.), Free. Pharm. Biol. Prod., 3rd ed., Informa Healthcare, New York, London, 2010, pp. 1–564. http://www.gbv.de/dms/bs/toc/376091975.pdf (accessed 08.08.17). Dehghan, 2012, Freeze-dried Xanthan/Guar Gum Nasal Inserts for the Delivery of Metoclopramide Hydrochloride, Iran. J. Pharm. Res. IJPR., 11, 513 Khorasani, 2015, Visualization and prediction of porosity in roller compacted ribbons with near-infrared chemical imaging (NIR-CI), J. Pharm. Biomed. Anal., 109, 11, 10.1016/j.jpba.2015.02.008 Genina, 2012, Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques, Eur. J. Pharm. Sci., 47, 615, 10.1016/j.ejps.2012.07.020 Modamio, 1996, Development and validation of liquid chromatography methods for the quantitation of propranolol, metoprolol, atenolol and bisoprolol: Application in solution stability studies, Int. J. Pharm., 130, 137, 10.1016/0378-5173(95)04257-1 Borges, 2015, Oral films: Current status and future perspectives, J. Control. Release, 206, 1, 10.1016/j.jconrel.2015.03.006 A. Krekeler, Formulation development and manufacturing of oral film preparations, in: PBP Worldmeeting, Glasgow, the United Kingdom, 2016. Boateng, 2010, Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces, Int. J. Pharm., 389, 24, 10.1016/j.ijpharm.2010.01.008 Kassem, 2015, Lyophilized sustained release mucoadhesive chitosan sponges for buccal buspirone hydrochloride delivery: formulation and in vitro evaluation, AAPS PharmSciTech., 16, 537, 10.1208/s12249-014-0243-3 Nussinovitch, 1993, Compressive characteristics of freeze-dried agar and alginate gel sponges, Biotechnol. Prog., 9, 101, 10.1021/bp00019a015 Garsuch, 2009, Novel analytical methods for the characterization of oral wafers, Eur. J. Pharm. Biopharm., 73, 195, 10.1016/j.ejpb.2009.05.010 Ayensu, 2012, In vitro characterisation of chitosan based xerogels for potential buccal delivery of proteins, Carbohydr. Polym., 89, 935, 10.1016/j.carbpol.2012.04.039 Boateng, 2009, In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug, Int. J. Pharm., 378, 66, 10.1016/j.ijpharm.2009.05.038 Vrentas, 1996, Surface concentration effects in the drying of solvent-coated polymer films, J. Appl. Polym. Sci., 60, 1049, 10.1002/(SICI)1097-4628(19960516)60:7<1049::AID-APP16>3.0.CO;2-W Ayensu, 2012, Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa, Colloids Surfaces B Biointerfaces., 91, 258, 10.1016/j.colsurfb.2011.11.004 Kianfar, 2014, Development and physico-mechanical characterization of carrageenan and poloxamer-based lyophilized matrix as a potential buccal drug delivery system, Drug Dev. Ind. Pharm., 40, 361, 10.3109/03639045.2012.762655 T. Rogers, Hypromellose, in: C. Rowe, P. Sheskey, M. Quinn (Eds.), Handb. Pharm. Excipients, 6th ed., Pharmaceutical Press and American Pharmacists Association, London Chicago, 2009, pp. 326–329. J. Collett, Poloxamer, in: C. Rowe, P. Sheskey, M.E. Quinn (Eds.), Handb. Pharm. Excipients, 6th ed., Pharmaceutical Press and American Pharmacists Association, 2009, pp. 506–509. Lim, 2013, Plasticizer effects on physical-mechanical properties of solvent cast soluplus® films, AAPS PharmSciTech., 14, 903, 10.1208/s12249-013-9971-z Bartolomei, 1998, Thermal studies on the polymorphic modifications of (R, S) propranolol hydrochloride, Thermochim. Acta. 321, 43, 10.1016/S0040-6031(98)00438-9 Vakili, 2016, Application of a colorimetric technique in quality control for printed pediatric orodispersible drug delivery systems containing propranolol hydrochloride, Int. J. Pharm., 511, 606, 10.1016/j.ijpharm.2016.07.032 Shaikh, 2011, Mucoadhesive drug delivery systems, J. Pharm. Bioallied Sci., 3, 89, 10.4103/0975-7406.76478